Nextech to Host Third Annual EDGE User Conference
February 20, 2017 14:00 ET | Nextech
TAMPA, FL--(Marketwired - February 20, 2017) - Nextech Systems, a leading provider of specialty-focused health care technology solutions for physician practices, is excited to host its third annual...
NVISION Eye Centers Hires Vice President of Corporate Development
February 14, 2017 08:00 ET | NVISION Eye Centers
ALISO VIEJO, Calif., Feb. 14, 2017 (GLOBE NEWSWIRE) -- NVISION Eye Centers—a national leader in providing the finest suite of ophthalmology services for patients including: custom and Topographic...
Jeff Lew Joins Nextech Systems as Vice President of Product Management
February 01, 2017 11:46 ET | Nextech
TAMPA, FL--(Marketwired - February 01, 2017) - Nextech Systems, a leading provider of specialty-focused health care technology solutions for physician practices, today announced the appointment of...
Professor Robert Ritch
Axim® Biotech Announces Addition of World-Renowned Opthamologist to Advisory Board
December 27, 2016 09:00 ET | AXIM Biotechnologies, Inc
NEW YORK, Dec. 27, 2016 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, is proud to announce the addition of...
Medical Biomimetics Market size worth $34.4 bn by 2024: Global Market Insights Inc.
September 20, 2016 06:30 ET | Global Market Insights
Ocean View, Delaware, Sept. 20, 2016 (GLOBE NEWSWIRE) -- Medical Biomimetics Market size is estimated to reach USD 34.4 billion by 2024; as per a new research report by Global Market Insights,...
Parion Sciences Announces Initiation of Phase 2 Clinical Trial of P-321 for the Treatment of Dry Eye Disease
July 26, 2016 07:59 ET | Parion Sciences
DURHAM, N.C,, July 26, 2016 (GLOBE NEWSWIRE) -- Parion Sciences, a company dedicated to the development of novel treatments for pulmonary and ocular diseases, announced today it has initiated a...
Parion Sciences Announces the Presentation of Clinical Data on P-321 Ophthalmic Solution for the treatment of Dry Eye Disease at the Association for Research in Vision and Ophthalmology (ARVO 2016)
May 02, 2016 08:02 ET | Parion Sciences
DURHAM, N.C., May 02, 2016 (GLOBE NEWSWIRE) -- Parion Sciences, a company dedicated to the development of novel treatments for pulmonary and  epithelial diseases, announced today the...
GenSight Biologics Enrolls First Patient in Pivotal Phase III Program of GS010 in Leber’s Hereditary Optic Neuropathy
February 29, 2016 07:00 ET | GenSight Biologics
PARIS, Feb. 29, 2016 (GLOBE NEWSWIRE) -- GenSight Biologics S.A. (GenSight), a clinical-stage biotechnology company discovering and developing novel gene therapies for neurodegenerative retinal...
eyepoint logo.png
pSivida CEO to Present at 18th Annual Bio CEO & Investor Conference February 9
January 28, 2016 10:30 ET | EyePoint Pharmaceuticals, Inc.
WATERTOWN, Mass., Jan. 28, 2016 (GLOBE NEWSWIRE) -- pSivida Corp. (NASDAQ:PSDV) (ASX:PVA), a leader in the development of sustained release drugs for treating eye diseases, today announced that...
Applied Genetic Technologies Logo
AGTC Announces Data Evaluating Novel AAV-Based Gene Therapy as a Potential Treatment for Alpha-1 Antitrypsin (AAT) Deficiency
January 20, 2016 07:01 ET | Applied Genetic Technologies Corporation
GAINESVILLE, Fla. and CAMBRIDGE, Mass. and PHILADELPHIA, Jan. 20, 2016 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq:AGTC), a biotechnology company conducting human clinical...